Is İt Possible to Diagnose Endometrium Cancer with the Levels of Prolactin, Eotaxin, E-selectin and Ca 125?
Objective: The aim of this study to evaluate possible serum markers for distinction of endometrial carcinoma (EC) from benign uterine gynecologic diseases. Methods: The study group consisted of 65 patients who were diagnosed with histologically confirmed EC were compared with 65 women who had operat...
Gespeichert in:
Veröffentlicht in: | Bezmialem Science 2019-10, Vol.7 (4), p.281-285 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: The aim of this study to evaluate possible serum markers for distinction of endometrial carcinoma (EC) from benign uterine gynecologic diseases. Methods: The study group consisted of 65 patients who were diagnosed with histologically confirmed EC were compared with 65 women who had operation indication for benign uterine diseases with fasting blood serum levels which were taken prior to surgery in terms of prolactin, eotaxin, e-selectin and Ca 125 concentrations. Results: Serum prolactin (20.7[+ or -]18 and 16.2[+ or -]13), eotaxin (219.4[+ or -]95 and 205.15[+ or -]80) and e- selectin (67.2[+ or -]29 and 61.5[+ or -]29) levels were not significantly different between EC and the other group (p>0.05). Ca 125 levels (36.6[+ or -]40 and 18.8[+ or -]9) were significantly higher in EC group when compared with the benign uterine patology group (p |
---|---|
ISSN: | 2148-2373 2148-2373 |
DOI: | 10.14235/bas.galenos.2019.2821 |